Growth strategy consulting firm CIL has hired Frédéric Thomas as a partner to lead its French operations and be part of its global healthcare and life sciences practice.

Thomas has experience providing strategic advisory services, transactional support, and value creation strategies to private equity firms and corporations across Europe, particularly in the life sciences sector.

Thomas was previously an equity partner at economic consultancy Roland Berger, where he helped enhance large-cap coverage within the life sciences sector and developed key accounts across Europe. He also led KPMG’s life sciences and healthcare sector for France for six years, driving commercial due diligence and post-deal value creation initiatives.

Earlier in his career, Thomas was a partner at management consulting firm Arthur D. Little, where he led the life sciences practice in France, focusing on multinational pharmaceutical groups and private equity-backed healthcare businesses. He also worked for seven years at Pfizer, where he managed high-performance organisational projects and business process optimisation. 

Jon Whiteman, managing partner at CIL, said: “I’m thrilled to welcome Frédéric to our senior team as we set the stage for CIL’s next chapter in France. His dynamic leadership and proven ability to drive growth, combined with his deep expertise in the life sciences sector, make him an invaluable addition. The opportunities ahead are vast, and I’m eager to see the progress we’ll make together in this rapidly evolving market.”

Thomas commented: “As we expand our presence in France and Europe, I’m looking forward to collaborating with the talented team here to drive growth and innovation.”